Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating income | $2.90M | -$20.7M | $2.90M | -$51.2M | -$68.9M | -$76.2M | -$83.9M |
| Net income | — | -$31.7M | -$30.6M | -$37.7M | -$64.5M | -$71.3M | -$75.8M |
| EPS (diluted) | — | -$5.17 | -$2.69 | -$10.33 | -$6.18 | -$4.89 | -$3.95 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | — | -$18.3M | -$33.7M | -$45.9M | -$52.1M | -$62.6M | -$77.2M |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.21M | $19.8M | $84.7M | $38.3M | $86.9M | $71.6M | $28.7M |
| Total assets | $102M | $23.4M | $93.7M | $48.4M | $94.9M | $79.9M | $35.8M |
| Total liabilities | $3.61M | $14.6M | $24.1M | $12.4M | $16.5M | $18.2M | $31.6M |
| Shareholders' equity | -$4.73M | -$35.1M | $69.5M | $36.0M | $78.4M | $61.7M | $4.15M |
| Retained earnings | $2.04K | -$36.8M | -$67.5M | -$105M | -$170M | -$241M | -$317M |
| Shares (wtd avg diluted) | — | 2.77M | 11.4M | 3.65M | 10.4M | 14.6M | 19.2M |
Every figure is extracted from Jasper Therapeutics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.